Sunday, August 17, 2008
:The Daily Star: Internet Edition
:The Daily Star: Internet Edition: "Treatment Of Thalassaemia
In quest of comprehensive treatment facilities
Star Health Correspondent
Thalassaemia is an inherited blood disease. In thalassemia, the genetic defect results in the formation of abnormal haemoglobin molecules, and this in turn causes the anaemia which is the characteristic presenting symptom of the thalassemias.
Other consequences of the disease are deposition of iron from the haemoglobin affecting the reticuloendothelial system of the body.
So the mainstay of thalassaemia treatment is blood transfusion at a regular interval and removing of iron from body by iron chelating agents.
If this can be maintained strictly, thalassaemia patients can also lead almost a normal and productive life. But most of the cases it does not happen. There remains various causes behind it.
First of all, patients seriously lack from proper knowledge about how to manage the disease and other important issues. Secondly comes the crisis of quality blood frequently. Sometimes patients get infected from poor quality blood. Thirdly, many patients cannot maintain the iron chelating agents. Sometimes availability of drug is a problem, while most often not maintaining a proper guideline is the serious issue.
Above all, handling all these issues from the childhood, patients and their families are very exhausted. Many patients are quite in a fix what to do,"
In quest of comprehensive treatment facilities
Star Health Correspondent
Thalassaemia is an inherited blood disease. In thalassemia, the genetic defect results in the formation of abnormal haemoglobin molecules, and this in turn causes the anaemia which is the characteristic presenting symptom of the thalassemias.
Other consequences of the disease are deposition of iron from the haemoglobin affecting the reticuloendothelial system of the body.
So the mainstay of thalassaemia treatment is blood transfusion at a regular interval and removing of iron from body by iron chelating agents.
If this can be maintained strictly, thalassaemia patients can also lead almost a normal and productive life. But most of the cases it does not happen. There remains various causes behind it.
First of all, patients seriously lack from proper knowledge about how to manage the disease and other important issues. Secondly comes the crisis of quality blood frequently. Sometimes patients get infected from poor quality blood. Thirdly, many patients cannot maintain the iron chelating agents. Sometimes availability of drug is a problem, while most often not maintaining a proper guideline is the serious issue.
Above all, handling all these issues from the childhood, patients and their families are very exhausted. Many patients are quite in a fix what to do,"
